Literature DB >> 30635649

CD70 defines a subset of proinflammatory and CNS-pathogenic TH1/TH17 lymphocytes and is overexpressed in multiple sclerosis.

Tessa Dhaeze1, Laurence Tremblay1, Catherine Lachance1, Evelyn Peelen1, Stephanie Zandee1, Camille Grasmuck1, Lyne Bourbonnière1, Sandra Larouche1, Xavier Ayrignac1,2, Rose-Marie Rébillard1, Josée Poirier2, Boaz Lahav2, Pierre Duquette1,2, Marc Girard1,2, Robert Moumdjian3, Alain Bouthillier3, Catherine Larochelle1,2, Alexandre Prat4,5.   

Abstract

CD70 is the unique ligand of CD27 and is expressed on immune cells only upon activation. Therefore, engagement of the costimulatory CD27/CD70 pathway is solely dependent on upregulation of CD70. However, the T cell-intrinsic effect and function of human CD70 remain underexplored. Herein, we describe that CD70 expression distinguishes proinflammatory CD4+ T lymphocytes that display an increased potential to migrate into the central nervous system (CNS). Upregulation of CD70 on CD4+ T lymphocytes is induced by TGF-β1 and TGF-β3, which promote a pathogenic phenotype. In addition, CD70 is associated with a TH1 and TH17 profile of lymphocytes and is important for T-bet and IFN-γ expression by both T helper subtypes. Moreover, adoptive transfer of CD70-/-CD4+ T lymphocytes induced less severe experimental autoimmune encephalomyelitis (EAE) disease than transfer of WT CD4+ T lymphocytes. CD70+CD4+ T lymphocytes are found in the CNS during acute autoimmune inflammation in humans and mice, highlighting CD70 as both an immune marker and an important costimulator of highly pathogenic proinflammatory TH1/TH17 lymphocytes infiltrating the CNS.

Entities:  

Keywords:  CD27/CD70 pathway; CD70+CD4+ T lymphocytes; TCR1640 transgene mouse model; TGF-β1; TGF-β3; blood-brain barrier; endothelial cells; experimental autoimmune encephalitis; multiple sclerosis; soluble CD70

Mesh:

Substances:

Year:  2019        PMID: 30635649      PMCID: PMC6804668          DOI: 10.1038/s41423-018-0198-5

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  1 in total

1.  Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation.

Authors:  R Q Hintzen; S M Lens; K Lammers; H Kuiper; M P Beckmann; R A van Lier
Journal:  J Immunol       Date:  1995-03-15       Impact factor: 5.422

  1 in total
  20 in total

1.  Oncostatin M triggers brain inflammation by compromising blood-brain barrier integrity.

Authors:  Doryssa Hermans; Evelien Houben; Niels Hellings; Bieke Broux; Paulien Baeten; Helena Slaets; Kris Janssens; Cindy Hoeks; Baharak Hosseinkhani; Gayel Duran; Seppe Bormans; Elizabeth Gowing; Chloé Hoornaert; Lien Beckers; Wing Ka Fung; Horst Schroten; Hiroshi Ishikawa; Judith Fraussen; Ronald Thoelen; Helga E de Vries; Gijs Kooij; Stephanie Zandee; Alexandre Prat
Journal:  Acta Neuropathol       Date:  2022-06-06       Impact factor: 15.887

2.  The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure.

Authors:  Herbert Renz-Polster; Marie-Eve Tremblay; Dorothee Bienzle; Joachim E Fischer
Journal:  Front Cell Neurosci       Date:  2022-05-09       Impact factor: 6.147

3.  Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia.

Authors:  Yifei Dong; Charlotte D'Mello; William Pinsky; Brian M Lozinski; Deepak K Kaushik; Samira Ghorbani; Dorsa Moezzi; Dennis Brown; Francisca C Melo; Stephanie Zandee; Tina Vo; Alexandre Prat; Shawn N Whitehead; V Wee Yong
Journal:  Nat Neurosci       Date:  2021-02-18       Impact factor: 28.771

Review 4.  The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review.

Authors:  Yu Liu; Jiayu Wang; Shuangyan Luo; Yi Zhan; Qianjin Lu
Journal:  J Autoimmun       Date:  2020-07-01       Impact factor: 7.094

5.  CD70 contributes to age-associated T cell defects and overwhelming inflammatory responses.

Authors:  Di Wang; Juan Du; Yangzi Song; Beibei Wang; Rui Song; Yu Hao; Yongqin Zeng; Jiang Xiao; Hong Zheng; Hui Zeng; Hongxin Zhao; Yaxian Kong
Journal:  Aging (Albany NY)       Date:  2020-06-19       Impact factor: 5.682

6.  Human CD4+ T cell subsets differ in their abilities to cross endothelial and epithelial brain barriers in vitro.

Authors:  Hideaki Nishihara; Sasha Soldati; Adrien Mossu; Maria Rosito; Henriette Rudolph; William A Muller; Daniela Latorre; Federica Sallusto; Mireia Sospedra; Roland Martin; Hiroshi Ishikawa; Tobias Tenenbaum; Horst Schroten; Fabien Gosselet; Britta Engelhardt
Journal:  Fluids Barriers CNS       Date:  2020-02-03

7.  IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8.

Authors:  Alba Sánchez-Fernández; Stephanie Zandee; Jesús Amo-Aparicio; Marc Charabati; Alexandre Prat; Cecilia Garlanda; Elan Z Eisenmesser; Charles A Dinarello; Rubèn López-Vales
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 8.  NK Cells in Autoimmune Diseases: Protective or Pathogenic?

Authors:  Meifang Liu; Shujuan Liang; Cai Zhang
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

9.  A Two-Step Process of Effector Programming Governs CD4+ T Cell Fate Determination Induced by Antigenic Activation in the Steady State.

Authors:  Adeleye Opejin; Alexey Surnov; Ziva Misulovin; Michelle Pherson; Cindy Gross; Courtney A Iberg; Ian Fallahee; Jessica Bourque; Dale Dorsett; Daniel Hawiger
Journal:  Cell Rep       Date:  2020-11-24       Impact factor: 9.423

10.  RNA-binding protein altered expression and mislocalization in MS.

Authors:  Katsuhisa Masaki; Yoshifumi Sonobe; Ghanashyam Ghadge; Peter Pytel; Paula Lépine; Florian Pernin; Qiao-Ling Cui; Jack P Antel; Stephanie Zandee; Alexandre Prat; Raymond P Roos
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.